These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Macritchie N; Grassia G; Sabir SR; Maddaluno M; Welsh P; Sattar N; Ialenti A; Kurowska-Stolarska M; McInnes IB; Brewer JM; Garside P; Maffia P Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2569-79. PubMed ID: 22936340 [TBL] [Abstract][Full Text] [Related]
3. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
4. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
6. Impaired Autophagy in CD11b Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723 [TBL] [Abstract][Full Text] [Related]
7. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice. Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice. Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice. Deshpande V; Krishnan R; Philip S; Faludi I; Ponnusamy T; Thota LN; Endresz V; Lu X; Kakkar VV; Mundkur LA Cardiovasc Ther; 2016 Oct; 34(5):314-24. PubMed ID: 27241889 [TBL] [Abstract][Full Text] [Related]